These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 19332801)

  • 1. Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component.
    O'Keefe BR; Vojdani F; Buffa V; Shattock RJ; Montefiori DC; Bakke J; Mirsalis J; d'Andrea AL; Hume SD; Bratcher B; Saucedo CJ; McMahon JB; Pogue GP; Palmer KE
    Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6099-104. PubMed ID: 19332801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide.
    Emau P; Tian B; O'keefe BR; Mori T; McMahon JB; Palmer KE; Jiang Y; Bekele G; Tsai CC
    J Med Primatol; 2007 Aug; 36(4-5):244-53. PubMed ID: 17669213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp.
    Mori T; O'Keefe BR; Sowder RC; Bringans S; Gardella R; Berg S; Cochran P; Turpin JA; Buckheit RW; McMahon JB; Boyd MR
    J Biol Chem; 2005 Mar; 280(10):9345-53. PubMed ID: 15613479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Griffithsin-Modified Electrospun Fibers as a Delivery Scaffold To Prevent HIV Infection.
    Grooms TN; Vuong HR; Tyo KM; Malik DA; Sims LB; Whittington CP; Palmer KE; Matoba N; Steinbach-Rankins JM
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6518-6531. PubMed ID: 27550363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro Study on Synergistic Interactions Between Free and Encapsulated Q-Griffithsin and Antiretrovirals Against HIV-1 Infection.
    Minooei F; Fried JR; Fuqua JL; Palmer KE; Steinbach-Rankins JM
    Int J Nanomedicine; 2021; 16():1189-1206. PubMed ID: 33623382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells.
    Alexandre KB; Gray ES; Mufhandu H; McMahon JB; Chakauya E; O'Keefe BR; Chikwamba R; Morris L
    Virology; 2012 Feb; 423(2):175-86. PubMed ID: 22209231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the carbohydrate-binding sites of griffithsin in the prevention of DC-SIGN-mediated capture and transmission of HIV-1.
    Hoorelbeke B; Xue J; LiWang PJ; Balzarini J
    PLoS One; 2013; 8(5):e64132. PubMed ID: 23741304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-generation HIV microbicides: continued development of griffithsin.
    Zeitlin L; Pauly M; Whaley KJ
    Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6029-30. PubMed ID: 19357305
    [No Abstract]   [Full Text] [Related]  

  • 9. Potent strategy to inhibit HIV-1 by binding both gp120 and gp41.
    Kagiampakis I; Gharibi A; Mankowski MK; Snyder BA; Ptak RG; Alatas K; LiWang PJ
    Antimicrob Agents Chemother; 2011 Jan; 55(1):264-75. PubMed ID: 20956603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Griffithsin Retains Anti-HIV-1 Potency with Changes in gp120 Glycosylation and Complements Broadly Neutralizing Antibodies PGT121 and PGT126.
    Fischer K; Nguyen K; LiWang PJ
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of silk fibroin biomaterial vehicle for in vivo mucosal delivery of Griffithsin and protection against HIV and SHIV infection ex vivo.
    Crakes KR; Herrera C; Morgan JL; Olstad K; Hessell AJ; Ziprin P; LiWang PJ; Dandekar S
    J Int AIDS Soc; 2020 Oct; 23(10):e25628. PubMed ID: 33073530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal of two high-mannose N-linked glycans on gp120 renders human immunodeficiency virus 1 largely resistant to the carbohydrate-binding agent griffithsin.
    Huang X; Jin W; Griffin GE; Shattock RJ; Hu Q
    J Gen Virol; 2011 Oct; 92(Pt 10):2367-2373. PubMed ID: 21715597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant production of anti-HIV protein, griffithsin, by auto-induction in a fermentor culture.
    Giomarelli B; Schumacher KM; Taylor TE; Sowder RC; Hartley JL; McMahon JB; Mori T
    Protein Expr Purif; 2006 May; 47(1):194-202. PubMed ID: 16300962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of griffithsin's interactions with human cells confirms its outstanding safety and efficacy profile as a microbicide candidate.
    Kouokam JC; Huskens D; Schols D; Johannemann A; Riedell SK; Walter W; Walker JM; Matoba N; O'Keefe BR; Palmer KE
    PLoS One; 2011; 6(8):e22635. PubMed ID: 21829638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic activity profile of griffithsin in combination with tenofovir, maraviroc and enfuvirtide against HIV-1 clade C.
    Férir G; Palmer KE; Schols D
    Virology; 2011 Sep; 417(2):253-8. PubMed ID: 21802104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rice endosperm is cost-effective for the production of recombinant griffithsin with potent activity against HIV.
    Vamvaka E; Arcalis E; Ramessar K; Evans A; O'Keefe BR; Shattock RJ; Medina V; Stöger E; Christou P; Capell T
    Plant Biotechnol J; 2016 Jun; 14(6):1427-37. PubMed ID: 26800650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral lectin Q-Griffithsin suppresses fungal infection in murine models of vaginal candidiasis.
    Nabeta HW; Lasnik AB; Fuqua JL; Wang L; Rohan LC; Palmer KE
    Front Cell Infect Microbiol; 2022; 12():976033. PubMed ID: 36329822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding site.
    Alexandre KB; Gray ES; Pantophlet R; Moore PL; McMahon JB; Chakauya E; O'Keefe BR; Chikwamba R; Morris L
    J Virol; 2011 Sep; 85(17):9039-50. PubMed ID: 21697467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of individual carbohydrate-binding sites in the function of the potent anti-HIV lectin griffithsin.
    Xue J; Gao Y; Hoorelbeke B; Kagiampakis I; Zhao B; Demeler B; Balzarini J; Liwang PJ
    Mol Pharm; 2012 Sep; 9(9):2613-25. PubMed ID: 22827601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The griffithsin dimer is required for high-potency inhibition of HIV-1: evidence for manipulation of the structure of gp120 as part of the griffithsin dimer mechanism.
    Xue J; Hoorelbeke B; Kagiampakis I; Demeler B; Balzarini J; Liwang PJ
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3976-89. PubMed ID: 23752505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.